Crinetics Pharmaceuticals Inc.
Clinical trials sponsored by Crinetics Pharmaceuticals Inc., explained in plain language.
-
New drug shows promise for hormone disorder in early trial
Disease control CompletedThis study tested a new medicine called CRN04894 in 38 adults with classic congenital adrenal hyperplasia, a genetic condition that disrupts hormone production. Participants took the drug for 12 weeks to see if it safely helps control hormone levels. The goal is to improve treatm…
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
New pill could ease carcinoid syndrome Flare-Ups
Symptom relief CompletedThis study tested a new drug called paltusotine in 36 adults with carcinoid syndrome, a condition that can cause flushing and diarrhea. The goal was to see if the drug is safe and how the body processes it at different doses. Participants took either 40 mg or 80 mg daily, with do…
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 08, 2026 12:02 UTC
-
New drug atumelnant put to the test in healthy people
Knowledge-focused CompletedThis early-stage study tested the safety and how the body processes a new drug called atumelnant in 21 healthy adults (both Japanese and Caucasian). Participants received either the drug or a placebo. The goal was to measure drug levels and check for side effects, not to treat an…
Phase: PHASE1 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC